117 related articles for article (PubMed ID: 38877363)
1. Pan-immune-inflammation value: a new prognostic index in operative laryngeal and pharyngeal carcinomas.
Shi J; Liu C; Yang N; Qiu C
Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38877363
[TBL] [Abstract][Full Text] [Related]
2. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract][Full Text] [Related]
3. Novel pretreatment nomograms based on pan-immune-inflammation value for predicting clinical outcome in patients with head and neck squamous cell carcinoma.
Chen Q; Wang SY; Chen Y; Yang M; Li K; Peng ZY; Xu CW; Yao XB; Li HH; Zhao Q; Cao YD; Bai YX; Li X
Front Oncol; 2024; 14():1399047. PubMed ID: 38915366
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
[TBL] [Abstract][Full Text] [Related]
5. Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.
Li F; Wang Y; Dou H; Chen X; Wang J; Xiao M
Front Oncol; 2024; 14():1349021. PubMed ID: 38380360
[TBL] [Abstract][Full Text] [Related]
6. Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer.
Lin F; Zhang LP; Xie SY; Huang HY; Chen XY; Jiang TC; Guo L; Lin HX
Front Oncol; 2022; 12():830138. PubMed ID: 35494034
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
8. Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer.
Kayar R; Bastug Y; Tokuc E; Topaktas R; Akyurek EA; Kayar K; Artuk I; Ozturk M
Int Urol Nephrol; 2024 Feb; 56(2):509-518. PubMed ID: 37773579
[TBL] [Abstract][Full Text] [Related]
9. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.
Şahin AB; Cubukcu E; Ocak B; Deligonul A; Oyucu Orhan S; Tolunay S; Gokgoz MS; Cetintas S; Yarbas G; Senol K; Goktug MR; Yanasma ZB; Hasanzade U; Evrensel T
Sci Rep; 2021 Jul; 11(1):14662. PubMed ID: 34282214
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pan-immune-inflammation value (PIV) in nasopharyngeal carcinoma patients.
Zhang N; Hou T; Zhang S; Ling J; Jiang S; Xie Y; Liu X; Hu C; Feng Y
Heliyon; 2024 Jan; 10(2):e24804. PubMed ID: 38312571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617.
Şahin E; Kefeli U; Zorlu Ş; Seyyar M; Ozkorkmaz Akdag M; Can Sanci P; Karakayali A; Ucuncu Kefeli A; Bakkal Temi Y; Cabuk D; Uygun K
Medicine (Baltimore); 2023 Nov; 102(47):e35843. PubMed ID: 38013293
[TBL] [Abstract][Full Text] [Related]
13. The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor.
Chen X; Hong X; Chen G; Xue J; Huang J; Wang F; Ali WADS; Li J; Zhang L
Transl Oncol; 2022 Mar; 17():101338. PubMed ID: 34999541
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy.
Russo P; Palermo G; Iacovelli R; Ragonese M; Ciccarese C; Maioriello G; Fantasia F; Bizzarri FP; Marino F; Moosavi K; Nigro D; Filomena GB; Gavi F; Rossi F; Pinto F; Racioppi M; Foschi N
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339402
[TBL] [Abstract][Full Text] [Related]
15. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
Fu M; Li Z; Ma J; Shen F; Zhang X
Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer.
Atasever Akkas E; Yucel B
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1945-1955. PubMed ID: 33837464
[TBL] [Abstract][Full Text] [Related]
17. Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma.
Su Z; Tang J; He Y; Zeng WH; Yu Q; Cao XL; Zou GR
Oncol Lett; 2024 Jun; 27(6):252. PubMed ID: 38646495
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Ann Surg Oncol; 2024 Jan; 31(1):272-283. PubMed ID: 37838648
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Efficiency of Pan-Immune-Inflammation Value to Predict Prostate Cancer in Patients with Prostate-Specific Antigen between 4 and 20 ng/mL.
Zhu M; Zhou Y; Liu Z; Jiang Z; Qi W; Chen S; Wang W; Shi B; Zhu Y
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769469
[TBL] [Abstract][Full Text] [Related]
20. Effect of preoperative pan-immune-inflammation value on clinical and oncologic outcomes after colorectal cancer surgery: a retrospective study.
Seo YJ; Kim KE; Jeong WK; Baek SK; Bae SU
Ann Surg Treat Res; 2024 Mar; 106(3):169-177. PubMed ID: 38435496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
